Neurocrine Biosciences, Inc. (NBIX)
146.10
-0.28
(-0.19%)
USD |
NASDAQ |
Oct 30, 16:00
146.15
+0.05
(+0.03%)
After-Hours: 20:00
Neurocrine Biosciences 30-Day Average Daily Volume : 1.318M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.318M |
| October 29, 2026 | 1.368M |
| October 28, 2026 | 1.380M |
| October 27, 2026 | 1.377M |
| October 26, 2026 | 1.382M |
| October 23, 2026 | 1.366M |
| October 22, 2026 | 1.361M |
| October 21, 2026 | 1.349M |
| October 20, 2026 | 1.357M |
| October 19, 2026 | 1.342M |
| October 16, 2026 | 1.339M |
| October 15, 2026 | 1.326M |
| October 14, 2026 | 1.315M |
| October 13, 2026 | 1.294M |
| October 12, 2026 | 1.300M |
| October 09, 2026 | 1.290M |
| October 08, 2026 | 1.281M |
| October 07, 2026 | 1.277M |
| October 06, 2026 | 1.273M |
| October 05, 2026 | 1.265M |
| October 02, 2026 | 1.248M |
| October 01, 2026 | 1.222M |
| September 30, 2026 | 1.192M |
| September 29, 2026 | 1.165M |
| September 28, 2026 | 1.154M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.150M |
| September 24, 2026 | 1.180M |
| September 23, 2026 | 1.211M |
| September 22, 2026 | 1.179M |
| September 21, 2026 | 1.170M |
| September 18, 2026 | 1.156M |
| September 17, 2026 | 1.108M |
| September 16, 2026 | 1.112M |
| September 15, 2026 | 1.118M |
| September 14, 2026 | 1.124M |
| September 11, 2026 | 1.250M |
| September 10, 2026 | 1.293M |
| September 09, 2026 | 1.299M |
| September 08, 2026 | 1.308M |
| September 04, 2026 | 1.316M |
| September 03, 2026 | 1.323M |
| September 02, 2026 | 1.334M |
| September 01, 2026 | 1.339M |
| August 31, 2026 | 1.353M |
| August 28, 2026 | 1.328M |
| August 27, 2026 | 1.332M |
| August 26, 2026 | 1.338M |
| August 25, 2026 | 1.330M |
| August 24, 2026 | 1.330M |
| August 21, 2026 | 1.342M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Amgen, Inc. | 2.742M |
| Halozyme Therapeutics, Inc. | 2.355M |
| BioCryst Pharmaceuticals, Inc. | 5.120M |
| Precigen, Inc. | 5.111M |
| BioMarin Pharmaceutical, Inc. | 2.343M |